secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)
CIK:        0001823239
Form:       8-K
Filed at:   2022-01-20T23:59:59+00:00
Accession:  0001823239-22-000004
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Maravai amends credit agreement; replaces LIBOR with SOFR, reduces interest margins, and refinances $544M term loans.
--------------------------------------------------------------------------------

- Amendment replaces LIBOR with Term SOFR; interest margin on Term SOFR loans reduced to 3.00% from 3.75%-4.25%.
- Base rate floor for term loans lowered from 2.00% to 1.50%; Term SOFR floor set at 0.50% (term) and 0.00% (revolving).
- New $544M Tranche B Term Loan facility refinances existing $600M Initial Term Loans via cashless conversion or new lender commitments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1823239/000182323922000004/0001823239-22-000004-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1823239/000182323922000004/mrvi-20220119.htm
  HTML page:      https://secwatch.observer/filing/0001823239-22-000004

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer